Literature DB >> 17142384

Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis.

S P Linn-Rasker1, A H M van der Helm-van Mil, F C Breedveld, T W J Huizinga.   

Abstract

OBJECTIVE: To investigate the predictive value of the distribution of inflamed joints at first presentation for the severity of the disease course in rheumatoid arthritis (RA).
METHODS: Of the 1009 consecutive patients included in the Leiden Early Arthritis Clinic (Leiden, The Netherlands), 285 patients fulfilled the American College of Rheumatology criteria for RA within 1 year of follow-up. Of these, 28 patients achieved remission. Radiographs of hands and feet were scored according to the Sharp-van der Heijde method, and the 28 patients with the most destructive disease were selected. The distribution of inflamed joints of the patients with the extreme disease courses was compared. The association between the distribution of inflamed joints and the level of destruction of the joints of hands and feet in the whole group of patients with RA was assessed using regression analysis.
RESULTS: Comparison of patients with extreme disease courses using univariate and logistic regression analyses showed that arthritis of the large joints - in particular, the knee - was associated with severe RA. In the whole group of patients with RA, the total number of swollen joints and the presence of knee arthritis were associated independently with the level of destruction of the small joints. Patients with RA with knee arthritis had higher C reactive protein (CRP) levels than patients without knee arthritis, and investigating the distribution of inflamed joints together with other variables yielded the number of swollen joints, CRP, presence of anti-cyclic citrullinated peptide antibodies and symptom duration as predictors for severity of RA.
CONCLUSION: Arthritis of large joints - in particular, the knee - at first presentation is associated with a destructive course of RA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142384      PMCID: PMC1954616          DOI: 10.1136/ard.2006.066704

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  How to read radiographs according to the Sharp/van der Heijde method.

Authors:  D van der Heijde
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

2.  Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.

Authors:  S Bas; S Genevay; O Meyer; C Gabay
Journal:  Rheumatology (Oxford)       Date:  2003-05       Impact factor: 7.580

3.  Prognostic markers of radiographic progression in early rheumatoid arthritis.

Authors:  Jörg J Goronzy; Eric L Matteson; James W Fulbright; Kenneth J Warrington; April Chang-Miller; Gene G Hunder; Thomas G Mason; Audrey M Nelson; Robert M Valente; Cynthia S Crowson; Henry A Erlich; Rebecca L Reynolds; Ronald G Swee; W Michael O'Fallon; Cornelia M Weyand
Journal:  Arthritis Rheum       Date:  2004-01

Review 4.  Radiological progression in established rheumatoid arthritis.

Authors:  David L Scott
Journal:  J Rheumatol Suppl       Date:  2004-03

5.  Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS).

Authors:  Jonathon Dixey; Csilla Solymossy; Adam Young
Journal:  J Rheumatol Suppl       Date:  2004-03

6.  Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients.

Authors:  Jennifer D Gorman; Raymond F Lum; John J Chen; Maria E Suarez-Almazor; Glenys Thomson; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2004-02

Review 7.  The Leiden Early Arthritis Clinic.

Authors:  J van Aken; J H van Bilsen; C F Allaart; T W Huizinga; F C Breedveld
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

Review 8.  The role of interleukin-1 in the pathogenesis of rheumatoid arthritis.

Authors:  J Kay; L Calabrese
Journal:  Rheumatology (Oxford)       Date:  2004-06       Impact factor: 7.580

9.  Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

Authors:  F A van Gaalen; S P Linn-Rasker; W J van Venrooij; B A de Jong; F C Breedveld; C L Verweij; R E M Toes; T W J Huizinga
Journal:  Arthritis Rheum       Date:  2004-03

10.  Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.

Authors:  Annette H M van der Helm-van Mil; Kirsten N Verpoort; Ferdinand C Breedveld; René E M Toes; Tom W J Huizinga
Journal:  Arthritis Res Ther       Date:  2005-06-14       Impact factor: 5.156

View more
  12 in total

Review 1.  Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Authors:  Kathleen Carey; Babak Saboury; Sandip Basu; Alex Brothers; Alexis Ogdie; Tom Werner; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-14       Impact factor: 9.236

2.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

3.  Radiographic estimation in seropositive and seronegative rheumatoid arthritis.

Authors:  Vjollca Sahatçiu-Meka; Sylejman Rexhepi; Suzana Manxhuka-Kërliu; Mjellma Rexhepi
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

4.  Enhanced MRI in early undifferentiated oligoarthritis of the knee joints: improvements already visible after 2 months of DMARDs treatment.

Authors:  Yasser Emad; Yasser Ragab; Ahmed Shaarawy; Hala Raafat; H A El-Kiki; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2008-06-18       Impact factor: 2.980

5.  The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis.

Authors:  Mohammed Z Cader; Andrew D Filer; Christopher D Buckley; Karim Raza
Journal:  BMC Musculoskelet Disord       Date:  2010-08-23       Impact factor: 2.362

Review 6.  The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis.

Authors:  Cristiano Alessandri; Roberta Priori; Mariagrazia Modesti; Riccardo Mancini; Guido Valesini
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

7.  Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.

Authors:  Yuichi Maeda; Toru Hirano; Kosuke Ebina; Ryota Hara; Motomu Hashimoto; Wataru Yamamoto; Kosaku Murakami; Takuya Kotani; Kenichiro Hata; Yonsu Son; Hideki Amuro; Akira Onishi; Sadao Jinno; Masaki Katayama; Atsushi Kumanogoh
Journal:  Rheumatol Int       Date:  2021-04-26       Impact factor: 2.631

8.  Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure.

Authors:  Carlo Alberto Scirè; Oscar Epis; Veronica Codullo; Frances Humby; Patrizia Morbini; Antonio Manzo; Roberto Caporali; Costantino Pitzalis; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 9.  Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?

Authors:  Frances Claire Humby; Farida Al Balushi; Gloria Lliso; Alberto Cauli; Costantino Pitzalis
Journal:  Front Med (Lausanne)       Date:  2017-05-03

10.  B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure.

Authors:  F Rivellese; F Humby; S Bugatti; L Fossati-Jimack; H Rizvi; D Lucchesi; G Lliso-Ribera; A Nerviani; R E Hands; G Giorli; B Frias; G Thorborn; E Jaworska; C John; K Goldmann; M J Lewis; A Manzo; M Bombardieri; C Pitzalis
Journal:  Arthritis Rheumatol       Date:  2020-03-17       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.